🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03691376
Treatments Being Tested
This trial will evaluate safety and efficacy of human engineered T-cell the...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2019-12-31
Trial ID
NCT03967223
Treatments Being Tested
Adoptive T-cell therapy is a therapeutic approach that aims to generate an ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-25
Trial ID
NCT03697824
Treatments Being Tested
This phase I trial studies the side effects of genetically modified T cells...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2017-12-08
Trial ID
NCT03017131
This trial will evaluate safety, tolerability, and efficacy of letetresgene...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-08-18
Trial ID
NCT03168438
New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1) is a cancer-testis...
Status
Recruiting
Location
TCRCure Biopharma Ltd.
Start Date
2023-06-01
Trial ID
NCT05881525
Treatments Being Tested
The purpose of this early (pilot) clinical trial is to test the effects (bo...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-09-27
Trial ID
NCT01343043
Treatments Being Tested
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053
This study will enroll patients with multiple myeloma who have received pri...
Status
Terminated
Location
City of Hope
Start Date
2013-10-15
Trial ID
NCT01892293
Treatments Being Tested